Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational, Prospective Study to Assess the Utility of a Speech-based Machine Learning Algorithm to Predict Treatment Response to Psychiatric Interventions

NCT06823024 is registered in ClinicalTrials.gov with Psyrin Inc. as lead sponsor.

NCT NCT06823024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06823024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational, Prospective Study to Assess the Utility of a Speech-based Machine Learning Algorithm to Predict Treatment Response to Psychiatric Interventions
Lead sponsor
Psyrin Inc.
Phase
Observational
Overall status
Enrolling by invitation
Start date
February 18, 2025
Completion date
March 31, 2026
Enrollment
200 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorders, generalized anxiety disorder (gad), major depressive disorder, obsessive compulsive disorder (ocd), post-traumatic stress disorder, ptsd